Psychiatric Pharmacists: Key Allies to Improve Antipsychotic Metabolic Monitoring

An investigation of new medications initiation during ambulatory care visits in patients with dementia

“…, 43 , 44 The role of a pharmacist in the outpatient setting to improve the management of these potentially inappropriate or high-risk medications may include patient education, adherence promotion, dosage adjustments, adverse effect management, and laboratory and toxicity monitoring. 45 , 46 , 47 , 48 , 49 …”

Role of Board‐Certified Psychiatric Pharmacists in child and adolescent psychiatry

“…8,10,[12][13][14][15]17,18,[20][21][22][23][24][25][26][27][28][29][30][31] Where properly integrated, BCPPs are viewed as valuable members of the CAP team by CAP, pediatricians, and foster care social workers, among others. 4,10,15,32 Through implementation of CMM, BCPPs address pediatric polypharmacy, increase medication adherence and knowledge, and enhance patient outcomes. 4,9,32,33 Board-Certified Psychiatric Pharmacists in CAP can also support medication decisions and monitoring for medical comorbidities.…”

“…4,10,15,32 Through implementation of CMM, BCPPs address pediatric polypharmacy, increase medication adherence and knowledge, and enhance patient outcomes. 4,9,32,33 Board-Certified Psychiatric Pharmacists in CAP can also support medication decisions and monitoring for medical comorbidities. 20…”

Improving Ambulatory Care Resident Training: Preparing for Opportunities to Treat Mental Illness in the Primary Care Setting

“…Although these recommendations are specified in the consensus statement, 23 follow-up studies have shown that screening rates have only increased gradually and are still infrequent 24 ; however, utilizing a pharmacist to assist with metabolic monitoring and CMM may improve the identification and management of these metabolic risks associated with antipsychotics. 25,26…”